SCHEMBL7658809

SCHEMBL7658809

CCOC(=O)c1ccc(N2CCCC2O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.52
HPGD P15428 3/20 0.52
ALDH1A1 P00352 5/20 0.50
TDP1 Q9NUW8 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
POLB P06746 1/20 0.50
HSP90AA1 P07900 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
FDFT1 P37268 1/20 0.49
MAPT P10636 2/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
ESR1 P03372 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
ESR2 Q92731 1/20 0.47
CA14 Q9ULX7 1/20 0.47
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL382515 0.85 HTT (0.51) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL18787387 0.84 HPGD (0.50) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL7459054 0.83 FDFT1 (0.49) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL382562 0.82 HTT (0.48) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL7051580 0.81 HPGD (0.50) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL21135465 0.80 HPGD (0.49) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL16479353 0.80 HTT (0.55) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL1096771 0.78 TDP1 (0.55) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL7470844 0.78 ALDH1A1 (0.50) HTTHPGDALDH1A1TDP1NPSR1
SCHEMBL11381594 0.78 HTT (0.59) HTTHPGDALDH1A1TDP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420558-B1 COMPOUNDS WITH AMIDINE GROUPS ANTAGONISTIC ACTIVITY, CELL ADHESION INHIBITORY ACTIVITY, HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY, AND THERAPEUTIC AGENTS MEIJI SEIKA KAISHA, LTD. (JP) 2002-07-16 US disclosed
EP-1074543-A1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA KAISHA LTD. (JP) 2001-02-07 EP disclosed